Specialty biopharmaceuticals player Vyome Biosciences today announced raising USD 14 million in a fresh round led by life sciences fund Perceptive Advisors and Romulus Capital.
Existing investors Kalaari Capital, Sabre Partners and Aarin Capital also participated, it said in a statement.
Vyome Biosciences is developing medicines for treating skin diseases caused by resistant microbes.
"We will utilise these funds predominantly to advance the clinical development of our lead product VB 1953," its co-founder and Chief Executive Venkateswarlu Nelabhotla said.
The company will continue to advance the development of other proprietary products in the pre-clinical stage, he added.
"The support from leading global and leading life investors and the continued support from our largest existing shareholders validates our company's strategy, science and development programs," he added.
Meanwhile, Uberdreams.Com today said it has raised USD 500,000 from Mascot Group.
The website offers 75 'experiences', including meeting celebrities and driving a luxury car.
Disclaimer: No Business Standard Journalist was involved in creation of this content
